Denmark consults on deadline extension for variations label updates
This article was originally published in SRA
Executive Summary
The Danish Medicines Agency is seeking feedback on whether it should extend, from six months to 12 months, the deadline under which pharmaceutical companies have to update their labelling and package leaflets following the authorisation of a variation application1.